| Bristol-Myers Squibb SA - Imnovid 2 mg, Hartkapseln | | 61249 | | 02 | | Imnovid 2 mg | | Hartkapseln | | L04AX06 | | Pomalidomide | | 02.06.2014 | | |
| | Composition | | pomalidomidum 2 mg, mannitolum, amylum pregelificatum, natrii stearylis fumaras corresp. natrium 0.036 mg, Kapselhülle: gelatina, E 171, E 132, E 127, E 172 (flavum), Drucktinte: lacca, E 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Pomalidomidum | 2 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pomalidomidum | 2 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Ammoniae Solutio | 28 | | | Amylum Pregelificatum | | | | E 127 | | color. | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Mannitol | | | | Natrii Stearylis Fumaras | | | | Per Centum | | | | Pro Capsula | | | | Propylenglycol | | | | Simeticone | | |
| |
| |
|
